CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 45 enrolled
Drug / intervention
Telehealthother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03184701
NCT03184701N/ACompleted

Remote Monitoring of Symptoms and Cognitive Function Using Telehealth

Albert Einstein Healthcare Network·interventional·Posted Jun 14, 2017·Updated Apr 17, 2020

In Brief

A clinical study evaluating Telehealth for End Stage Liver Disease. Completed, enrolled 45 participants across 1 site.

Detailed Summary

End-Stage Liver Disease (ESLD) is one of the ten leading causes of death in US. It is marked by episodic acute exacerbations of the underlying liver disease which often leads to severe symptoms, poor quality of life, mental deterioration and repeated hospitalizations. The overall purpose of this project is to introduce a telehealth based intervention (involving remote monitoring of symptoms and cognitive function initiated at the time of discharge of ESLD patients. This will support enhanced clinical care and improve self-management in ESLD population. In addition, it will reduce healthcare utilization, improve medication adherence and overall health outcomes

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 14, 2017
Enrollment StartApr 30, 2016
Primary CompletionAug 30, 2018
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 9.0 years ago

Interventions

Telehealthother

Patients will be given an ipad with preloaded app (secured questions assessing their symptoms and cognitive function in a systematic timely way). The responses will be delivered to the care providers instantly, which will trigger an algorithmic clinical approach.